Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Obesity

Semaglutide ingredient can help protect kidney function in people with obesity

Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has been shown in the SELECT Trial to be effective in preventing the loss of kidney function in people who are overweight or obese and have established cardiovascular disease but do not have diabetes. Read further on Dynamite News:

Dynamite News

9 Wild Moments From The New South Park Special About Ozempic: From Murderous Mums To Ear Shitting

South Park: The End Of Obesity about Ozempic has finally landed on Paramount+ and it's bonkers. Here are the top 9 mind-blowing moments.

Pedestrian.tv

Lizzo gratified by South Park name check

In the "End of Obesity" special, South Park residents want the latest semaglutides, but there's a cheaper option

Salon

From analysis to the latest developments in health,
read the most diverse news in one place.

Study sheds more light on ability of cancer drug to lower blood sugar

The efficacy of a medication to prevent liver fat accumulation--a condition that frequently coexists with obesity and can result in dangerous fatty liver disease--has been further explored by researchers at the University of Oklahoma. Read further on Dynamite News:

Dynamite News

Weight-loss jabs shouldn’t be quick-fix solution for governments, says expert

Obesity prevention is cheaper long-term option, says Cambridge professor, with focus on dietary advice and exercise plans

The Guardian - UK

Ark Invest CEO Cathie Wood Boosts Stake in Firms Making Breakthroughs in Gene Editing, AI Drug Development, and Obesity Drugs

Cathie Wood splurged millions in biotech this year on strong clinical progress, AI adoption, sales growth, wider outreach, and steady product pipelines.

International Business Times UK

Ozempic use among children and young adults soars by 600%

The report shows that the number of 12- to 25-year-olds using any GLP-1 drugs climbed by almost 600%

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Ozempic and Wegovy are all the rage—but people are quitting them too fast to achieve meaningful weight loss, per the largest GLP-1 study yet

Sales of antiobesity drugs hit $1.1 billion in the second quarter of 2023.

Fortune

Sharp rise in type 2 diabetes among people under 40 in UK

Diagnoses up 39% in six years, with condition fuelled by obesity, health inequalities and junk food, study finds

The Guardian - UK

This is the best time of day to exercise for people living with obesity, new study shows

One hormone in particular may explain the health benefits of physical activity at this time.

Fortune

UoH and NIN scientists study obesity-linked kidney ailment

Research explores obesity-induced kidney injury, proteinuria, and WT1 reactivation as a potential target for prevention and treatment.

The Hindu

50 Pictures Of School Lunches That Shocked People In A Good Or Bad Way

Have a look at some intriguing school lunches from around the world! The post 50 Pictures Of School Lunches That Shocked People In A Good Or Bad Way first appeared on Bored Panda.

Bored Panda

No screens at meals and insect food: four fresh findings about obesity

The European Congress on Obesity conference in Venice also hears about how financial incentives could help men lose weight

The Guardian - UK

General, central obesities linked to higher risk of colorectal cancer

While researchers have known that obese individuals have a higher risk of colorectal cancer, a new study reports evidence not all obese people are at equal risk. Instead, the risk seems to be higher for those who are “generally obese” and those who are “tall and centrally obese”.

The Hindu

Get all your
news in one place.

100’s of premium titles.
One news app.

International Business Times UK

NHS Is Paying Obese Men £400 To Lose Weight and Texting Them to 'Avoid the Kebab Shop'

Cash for weight loss? UK experts say it could save NHS money on diabetes and heart disease, but mental health risks of obesity add complexity.

Medical Daily

Severe Obesity In Childhood Halves Life Expectancy, Weight Loss Brings Back Decades: Study

A child with severe obesity at age 4 has only a life expectancy of 39 if the individual does not lose weight. However, losing weight could add decades back to their lives, the study revealed.

The Guardian - UK

Cash incentives may help men lose weight, research finds

Men with obesity offered incentives and sent healthy-eating tips in Game of Stones trial found to have lost most weight

The Guardian - UK

Wednesday briefing: The study that says semaglutide can do much more than help you lose weight

In today’s newsletter: A new study suggests semaglutides reduce not just obesity but risks to your heart too. What will that mean for their availability on the NHS?

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - UK

Young children with persistent severe obesity could have half average life expectancy, study finds

Research finds four-year-old boy who remains severely obese into adulthood has life expectancy of 39

Medical Daily

Source Of Sugar Matters More Than Amount For Childhood Obesity: Study

Children who get more sugar from sweet snacks, confectioneries, sweetened milk, and yogurt drinks, have a higher risk of gaining weight, the study revealed.

Barchart

1 'Strong Buy' Dividend Stock to Buy and Hold

Discover why Eli Lilly is considered a 'strong buy' as it capitalizes on the growing demand for diabetes and obesity treatments, backed by its robust financial performance and promising future prospects.

The Guardian - UK

Overweight people more likely to take sick leave, European study finds

Economic impact laid bare by findings has implications for UK where about two-thirds of people are overweight or obese

Evening Standard

Four in 10 cancer cases linked to obesity, study finds

European Congress on Obesity in Venice shares alarming health findings

Medical Daily

Study Explains How Night Shift Workers Are Prone To Diabetes, Obesity

Working on the night shift for as little as three days can disrupt the protein rhythms, raising the risk of diabetes, a recent study has revealed.

The Hindu

‘Ozempic seemed to change more than the patients’ bodies,’ says Johann Hari, author of Magic Pill

Writer-journalist Johann Hari brings himself into the Ozempic conversation, taking readers through the risks of obesity, its causes and effects, and what the drug does

1 … 22 23 24 25

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the University of Oklahoma

19 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.